What level of evidence does the prospective pre‑post implementation cohort study of structured outpatient diabetes education with telephone/text‑message follow‑up for adults with type 2 diabetes (HbA1c ≥ 8%) provide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Level of Evidence: Level III (Moderate Quality)

The prospective pre-post implementation cohort study by 1 represents Level III evidence according to standard evidence hierarchies—a quasi-experimental design without randomization or a concurrent control group.

Evidence Classification Rationale

This study design falls into the moderate-quality category because:

  • Pre-post implementation design: Participants serve as their own controls, measuring outcomes before and after the intervention without a separate control group receiving usual care simultaneously
  • No randomization: All eligible patients (HbA1c ≥8%) received the intervention; there was no random allocation to treatment versus control
  • Single-arm cohort: The 27 participants with complete data all received structured diabetes education plus telehealth follow-up
  • Prospective data collection: Strengthens the design compared to retrospective studies, but doesn't overcome the lack of a control group

Contextualizing the Evidence Quality

While this study demonstrated a statistically significant 1.7% reduction in HbA1c (P < .001) 1, the pre-post design has inherent limitations:

  • Regression to the mean: Patients with very high HbA1c (≥8%) may naturally improve somewhat over time
  • Temporal confounders: Other changes in the clinic or healthcare system during the 3-month period could contribute to improvements
  • Selection bias: The 7 participants without complete outcome data (21% attrition) may differ systematically from completers

Comparison to Higher-Quality Evidence

The intervention components (structured education + telehealth) are supported by stronger evidence:

  • Structured diabetes education: Recent meta-analysis of 49 RCTs showed -0.55% HbA1c reduction 2, providing Level I evidence for this component
  • Text message interventions: Meta-analysis of 37 RCTs demonstrated -0.32 standardized mean difference in HbA1c 3, again Level I evidence
  • Telehealth modalities: Guidelines acknowledge growing evidence for telehealth effectiveness in glycemic management 4

The individual study 1 provides hypothesis-generating evidence that combining these evidence-based components works in a real-world free clinic setting, but the pre-post design limits causal inference compared to randomized controlled trials.

References

Related Questions

A 62-year-old diabetic patient with HbA1c of 6.2% presents with a 1‑cm superficial circular scar on the dorsal aspect of the little toe from shoe irritation, without bleeding, drainage, or signs of infection. Does this patient require antibiotics?
In a 62-year-old woman with a hemoglobin A1c of 6.5% (improved from 6.9% with diet and exercise) and a creatinine clearance of 51 mL/min, should pharmacologic therapy for diabetes be initiated?
Is an HbA1c of 6.4% considered pre‑diabetes?
How should a 72-year-old patient with an HbA1c of 6.6% be managed?
In a 26-year-old woman with an HbA1c of 12.3%, how can I determine whether she has type 1 or type 2 diabetes?
Is orthostatic hypotension common in Parkinson disease?
What is the risk of recurrent pulmonary embolism from migrating clot fragments after a patient has clinically improved?
What are the cardiac manifestations of severe hyponatremia?
How does a patient's environment impact affect regulation and what environmental modifications can improve it?
What is a naltrexone challenge test?
When can a colonoscopy be safely performed after recent hospitalization for pulmonary embolism and ongoing therapeutic anticoagulation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.